Portfolio Growth NSV backs breakthrough science across Life Sciences and Information Technology, with portfolio companies such as Paragraf, Isorg, BrightVolt, DUST Identity, and VUV Analytics, signaling strong demand for growth-stage support in hardware, materials, and sensors. Opportunity: tailor growth and scale-up offerings in manufacturing, regulatory compliance, and go-to-market programs for these segments.

Investment Thesis The firm's deep-tech thesis spans graphene electronics, sensors, high-performance semiconductors, and enterprise software, suggesting a fit for vendors delivering specialized R&D support, IP management, data infrastructure, and scalable testing services to portfolio companies. Opportunity: position as a partner for technical due diligence, collaboration facilitation, and strategic pilots.

Leadership Access With a small team led by Somu Subramaniam and Tom Lavin, NSV can move quickly on partnerships; executive-level outreach can accelerate co-investments, pilots, or strategic collaborations. Opportunity: engage with concise value propositions and clear ROI expectations.

Capital Readiness Over $700M in assets under management signals an established fundraising base and potential for co-investments and advisory services for NSV and its LP network. Opportunity: offer co-investment structures, market insights, and fundraising support tailored to NSV’s ecosystem.

NYC Ecosystem Based in New York and active across frontier tech, NSV sits at a nexus of biotech, semiconductors, and software; this proximity supports partnerships, pilots, and accelerator-style collaborations with portfolio companies. Opportunity: propose NYC-based partnerships, pilot programs, or events to accelerate portfolio growth.